Wells Fargo maintains a 'Market Perform' on Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP), raises valuation range from $18-19 to $21-24.

Wells ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE